The article, *Crystal structure of HINT from *Helicobacter pylori** by K. F. Tarique *et al.* (2016[@bb16]) has come to my attention as containing several factual errors in the Introduction regarding the nature and annotation of HINT enzymes. As an author cited by this paper, I feel that it is necessary to provide corrections for the benefit of interested readers.

The HINT proteins are well established as performing hydrolysis on a wide variety of phosphoramidates and acyl-nucleotides (Bieganowski *et al.*, 2002[@bb2]; Chou *et al.*, 2007[@bb5]; Chou & Wagner, 2007[@bb6]). Interest in these enzymes has renewed recently as HINT1 is responsible for the cellular activation of blockbuster antiviral phosphoramidate nucleotide prodrug sofosbuvir by cleaving the bond between the phosphorous and nitrogen (Murakami *et al.*, 2010[@bb14]). Tarique *et al.* mischaracterize the catalysis as hydrolysis of the adenine nucleobase from the ribose and identify the substrate of the HINT proteins as phosphoramidites, an error in substrate oxidation state.

The structure of the protein now known as HINT1 (also hHint1) was first solved in 1996 at Columbia by the Hendrickson group. The bovine homolog of this protein had been identified biochemically as an inhibitor of protein kinase C (PKC) (McDonald & Walsh, 1985[@bb13]), giving rise to the initial annotation of protein kinase C interacting protein 1 (PKCI-1) in three associated PDB structures ([1kpa](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=1kpa), [1kpb](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=1kpb), and [1kpc](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=1kpc)). However, even in this first paper, there was doubt about the veracity of the PKC activity, '...other investigators have characterized a protein similar to bovine PKCI-1 from other organisms and have not been able to demonstrate inhibitory effect on PKC activity... In addition, some doubt has been cast on the physiological relevance of PKC inhibition by bovine PKCI-1' (Lima *et al.*, 1996[@bb11]). A year later, an enzymatic function of nucleotide diphos­phate hydrolysis was demonstrated (associated structures [1av5](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=1av5), [1kpe](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=1kpe), and [1kpf](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=1kpf)) (Lima *et al.*, 1997[@bb10]).

That same year, the Petsko group at Brandeis also purified and crystallized rabbit HINT (associated structures [3rhn](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=3rhn), [4rhn](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=4rhn), [5rhn](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=5rhn), [6rhn](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&pdbId=6rhn)), saying, 'HINT is nearly identical to proteins that have been given the designation protein kinase C inhibitor-1 (PKCI-1). Bovine PKCI-1 was so named because it was present in brain cytosol fractions that inhibited a mixture of PKC isoforms (McDonald & Walsh, 1985[@bb13]). It has not been possible to reproduce this inhibition with HINT from rabbit heart or with purified recombinant HINT.' (Brenner *et al.*, 1997[@bb4]) It was this publication that gave HINT proteins their name.

In 1999, Brenner *et al.* devoted an entire section of a review article to the pervasive annotation of HINT as PKCI-1, insisting that 'Hint is not a PKC inhibitor' (Brenner *et al.*, 1999[@bb3]). They noted that this enzyme is highly conserved, even in organisms that do not have PKC homologs, such as most bacteria. In fact, the appellation of PKCI-1 as an inhibitor of protein kinase C had been downgraded from heat-stable to heat-labile in 1991 (Fraser & Walsh, 1991[@bb9]), and there had been no success in replicating this activity, as mentioned above. The resurgence of this annotation is attributed, by Brenner *et al.*, to yeast two-hybrid experiments that expressed fragments of the human HINT cDNA sequence, which matched the defunct PKCI-1 references in protein databases. One of the yeast two-hybrid screens identified PKC-β as a binding partner for HINT, but further analysis showed that this was only an artifact of using a HINT fragment, rather than the full sequence (Brenner *et al.*, 1999[@bb3]). This 1999 article presented a clear history of why the PKCI-1 annotation had been used and why it is inappropriate to continue using it.

Since this time, the structural literature has been consistent in identifying analogous proteins using the HINT nomenclature (Bardaweel *et al.*, 2010[@bb1]; Ozga *et al.*, 2010[@bb15]; Dolot *et al.*, 2012[@bb7], 2013[@bb8]; Wang *et al.*, 2012[@bb17]; Maize *et al.*, 2013[@bb12]) until *Crystal structure of HINT from *Helicobacter pylori** (Tarique *et al.*, 2016[@bb16]), which not only reintroduces the abandoned PKCI-1 annotation, but also asserts that PKCI-1 is a distinct family member, rather than just another name for HINT1. It is unclear where the authors got their information, as the papers that they cite in the introduction clearly express either doubt or outright condemnation that HINT inhibits protein kinase C (Lima *et al.*, 1996[@bb11]; Brenner *et al.*, 1999[@bb3]).
